Embed Size (px)
Citation preview
MEDIA HOSTS
The International Society of DNA Vaccines Presents
DNA VACCINES 2011Building on Clinical Progress and Exploring New Targets
The International Society of DNA Vaccines Presents
DNA VACCINES 2011Building on Clinical Progress and Exploring New Targets
July 12 — 14, 2011Loews Coronado Bay, San Diego, CA
The International Society of DNA Vaccines Presents
DNA VACCINES 2011Building on Clinical Progress and Exploring New Targets
July 12 — 14, 2011Loews Coronado Bay, San Diego, CA
BioConferences International, Inc.140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801-5215
Name
Degree(s) Title
Affi liation
Address
City State Zip
Phone Fax
Special Dietary Needs
BioConferences International, Inc. 140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801-5215
Tel: 914-740-2100
Fax: 914-740-2105
www.bioconferences.com/dna
PLEASE CHECK ALL APPROPRIATE BOXES
Category Early Bird Regular On Sitebefore 6/6/11 6/7/11 - 7/1/11 after 7/1/11
Regular Rate* $899 $999 $1099
Poster/Presenter Rate $500 $600 $675
Student/Trainee Rate $400 $500 $575
Cancellation policy: Please be advised of our cancellation policy: Written
cancellations received prior to June 10, 2011, will receive a refund minus an
administrative charge of $200. Cancellation after this date is non-refundable;
however, substitutions from the same company are welcomed. If for any reason
this conference is cancelled, BioConferences International, Inc. is not responsible
for covering airfare, hotel or other cost incurred by conference registrants.
Payment Options Enclosed is my check/money order for $ make checks payable to BioConferences International, Inc. in US Currency and drawn on a US bank.
Charge in the amount of $
American Express Visa/Mastercard Discover
Card #
Exp. Date
Name on Card
Billing Address
Signature
—On-line registration at www.bioconferences.com/dna—
JULY 12–14, 2011 LOEWS CORONADO BAY, SAN DIEGO, CA
*Included with regular registration is a 1 year membership to the International
Society of DNA Vaccines.
CORPORATE SPONSORS
CHAIR’S CUP
SILVER SPONSOR
PROMOTIONAL SPONSOR FACULTY SPONSOR
GOLD SPONSOR
®
• AIDS Research and Human Retroviruses
www.liebertpub.com/aid
• Cancer Biotherapy & Radiopharmaceuticals
www.liebertpub.com/cbr
• DNA and Cell Biology
www.liebertpub.com/dna
• Genetic Testing and Molecular Biomarkers
www.liebertpub.com/gte
• Human Gene Therapy
www.liebertpub.com/hum
• Journal of Interferon & Cytokine Research
www.liebertpub.com/jir
• Lymphatic Research and Biology
www.liebertpub.com/lrb
• Oligonucleotides
www.liebertpub.com/oli
• OMICS: A Journal of Integrative Biology
www.liebertpub.com/omi
• Viral Immunology
www.liebertpub.com/vim
The International Society of DNA Vaccines Presents
DNA VACCINES 2011Building on Clinical Progress and Exploring New Targets
JULY 12 — 14, 2011Loews Coronado Bay, San Diego, CA
WWW.BIOCONFERENCES.COM/DNA
REGISTER NOW!Register now for the most innovative and important DNA Vaccines meeting in 2011,
at the low early bird rates while they are in eff ect. This is the only meeting presented
by the International Society of DNA Vaccines, the society covering this industry. This
regular early bird rate includes a one year complimentary membership to the society.
Program Chair and DNA Guru, David B. Weiner, PhD, University of Pennsylvania, has
brought together an extraordinary group of stellar presenters from all over the world,
who will be presenting exciting cutting-edge scientifi c research and the latest fi ndings
in the progressive fi eld of DNA or genetic vaccines, not covered at any other meeting.
All of this and more under the theme - Building on Clinical Progress and Exploring New
Targets. Organized by: BioConferences International, Inc.
For sponsorship information contact:
Harriet I. Matysko: [email protected]
tel: 914-740-2182
For registration or abstract submission contact:
www.bioconferences.com/dna
Toll free in USA: 1-800-5-BIOCON (800-524-6266)
SCIENTIFIC ADVISORY
PROGRAM CHAIR
SPEAKERS FOR TUESDAY, JULY 12 SPEAKERS FOR WEDNESDAY, JULY 13
SPEAKERS FOR THURSDAY, JULY 14
Britta Wahren
Karolinska Institutet, Sweden
Freda Stevenson
University of Southampton, UK
Dennis Klinman
NCI, USA
Bin Wang
Fudan University Shanghai
Medical College, China
Richard Heller
Old Dominion University, USA
Jeff rey Ulmer
Novartis, USA
John Shiver
Merck, USA
Ruxandra Draghia-Akli
EC, Belgium
George Pavlakis
NCI, USA
Paul Offi t
Children’s Hospital of
Philadelphia, USA
Stanley Plotkin
Wistar Institute, University of
Pennsylvania, Johns Hopkins
Bloomberg School of Public
Health and Sanofi Pasteur, USA
Niranjan Sardesai
Inovio, USA
Adel A. Mahmoud
Princeton University, USA
Shan Lu
University of Massachusetts,
USA
Connie W. Schmaljohn
USAMRIID, USA
Jeong-Im Sin
Kangwon National University,
Korea
Harriet Robinson
Geovax, USA
Jedd Wolchok
Memorial Sloan-Kettering
Hospital, USA
Kathrin Jansen, Pfi zer, USA
David B. Weiner, PhD
University of Pennsylvania
COMMERCIAL & SPONSORSHIP ADVISORY
J. Joseph Kim, PhD, CEO
Inovio
Bryan Byong Jin Kim, DMD,
President & CEO
VGXI
Michael Chambers,
President & CEO
Aldevron
Clague P. Hodgson, PhD,
President
Nature Technology
Henry L. Hebel, Chief
Operating Offi cer
VGXI
Derek Gregg, CEO
Vandalia Research
John Terlingo, Director,
RecipharmCobra Biologics
SCHEDULE OF EVENTS
David B. Weiner, PhD
Professor, University of Pennsylvania
Vaccines for Diffi cult Pathogens
Stanley Plotkin, MD
Emeritus Professor, Wistar Institute and University of
Pennsylvania, Professor Johns Hopkins Bloomberg School of
Public Health and Consultant, Sanofi Pasteur
John Shiver, PhD
Vice President, Vaccines Discovery, Merck
The Future of Vaccines
Richard Wyatt, PhD
Director of Viral Immunology, IAVI Center for Neutralizing
Antibodies at TSRI, Professor of Immunology, The Scripps
Research Institute
Antibody and B Cell Responses to the HIV-1 Envelope Glycoproteins
Susan Barnett, PhD
Senior Project Leader, Senior Director, Vaccine Research, Novartis
Vaccines & Diagnostics
Prime-boost Strategies for Protective Immunity against HIV
Harriet Robinson, PhD
Chief Scientifi c Offi cer, GeoVax
GeoVax DNA/MVA HIV Vaccine, Preclinical and Clinical Studies
Shan Lu, MD, PhD
Professor, University of Massachusetts Medical School
DNA Priming Immunization for Antibody Responses
Britta Wahren, MD, PhD
Professor, Karolinska Institutet, Sweden
Preclinical and Clinical Approaches to Genetic HIV Vaccines
Barbara Felber, PhD
Principal Investigator, NCI
DNA and Protein Vaccination Confers Protection upon Mucosal
Challenge with Heterologous SIVsmE660 in Rhesus Macaques
Alain Rolland, PhD
Executive Vice President, Vical
Phase 2 Clinical Trial Results of a Therapeutic DNA Vaccine,
TransVax™, for Control of Cytomegalovirus in Hematopoietic Cell
Transplant Recipients
Connie Schmaljohn, PhD
Chief Scientist, USAMRIID
Vaccine for Agents of Bioterrorism
Gary Kobinger, PhD
Chief, Special Pathogens, PHAC, Canada
Vaccines for Pandemics
Jeff rey Ulmer, PhD
Global Head, External Research, Novartis Vaccines & Diagnostics
Kathrin Jansen, PhD
Senior Vice President of Vaccine Research & Early Development,
Pfi zer, Inc.
Niranjan Sardesai, PhD
Senior Vice President, Inovio Pharmaceuticals, Inc.
Mike Betts, PhD
Assistant Professor, University of Pennsylvania
Novel Approaches to T Cell Analysis in Vaccination
Shane Crotty, PhD
Associate Member, La Jolla Institute for Allergy & Immunology
Follicular Helper CD4 T Cell Diff erentiation and the Development of
Protective Antibody Responses
Bin Wang, PhD
Professor, Fudan University, China
New Applications of DNA Vaccines
Drew Hannaman
Vice President, Ichor Pharmaceuticals
Expanded Clinical Testing of an Integrated Device Technology for
Electroporation Mediated DNA Vaccine Delivery
Thomas Richie, MD, PhD
Captain, Medical Corps, US Navy
New Malaria Vaccines
Thomas Evans, MD
CSO, Aeras
DNA Vaccines for Tuberculosis
Matti Sällberg, PhD
Professor, Karolinska Institutet, Sweden
Approaches to HCV Virus Infection
Philip Bergman, PhD
BrightHeart Veterinary Centers
Michele Kutzler, PhD
Assistant Professor, Drexel University
Targeting T Cells through Vaccination
Jeong-Im Sin, PhD
Professor, Kangwon National University, Korea
Antitumor Therapeutic Effi cacy of cDNA Delivered by Electroporation in
Animal Tumor Models
Ashley Birkett, PhD
Director, Pre and Early Clinical Research & Development, PATH Malaria
Vaccine Initiative
Margaret Liu, MD
Principal, ProTherImmune, Executive Vice-Chair, International Vaccines
Institute, Korea, Foreign Adjunct Professor, Karolinska Institutet, Sweden
Richard Heller, PhD
Professor, Medical Laboratory and Radiation Sciences, Old Dominion
University
Immunotherapy for Cancer Facilitated by Electro Gene Transfer
Cornelia Trimble, MD
Associate Professor, Johns Hopkins University School of Medicine
Therapeutic HPV Vaccines
Mark Bagarazzi, MD
Chief Medical Offi cer, Inovio Pharmaceuticals, Inc.
Clinical Studies of DNA Vaccination
Christian Ottensmeier, MD, PhD
Professor, University of Southampton, UK
Cancer Immune Therapy
Adil Daud, MD
Clinical Professor of Medicine & Dermatology, Director of Melanoma
Program, University of California at San Francisco
Electroporative Gene Therapy with IL-12 Plasmid in Metastatic Melanoma
Matthew Morrow, PhD
Research Scientist, PPD Vaccines & Biologics
Immune Assays for Vaccine Development
Philip Greenberg, MD
Professor, University of Washington
Targeting Tumors with T cells: The Normal Repertoire and Beyond
Genevieve Inchauspe, PhD
Head of Infectious Diseases Department, Transgene, France
Lessons from Poxviral Vaccines
DNA Vaccines 2011 will be held at the Loews Coronado Bay. A block of
rooms is being held at the conference rate of $199 per night.
Hotel room reservations for the conference can be made via our
dedicated booking website:
http://www.loewshotels.com/en/Coronado-Bay-Resort/GroupPages/DNA
You may also reserve your hotel room using the following reservation
phone lines: 619-424-400/800-815-6397. Please be sure to mention
that you are attending DNA Vaccines 2011.
Rooms are limited. Reservations must be made no later than June 13,
2011, to receive the discounted rate
RESERVE YOUR ROOM TODAY
Schedule for this 3 day meeting Tuesday, Wednesday and
Thursday July 12–14
This 3 day meeting commences at 7:30AM with Breakfast on July 12th
and concludes at 5:00PM on Thursday July 14th.
Breakfast at 7:30AM each morning with sponsors in exhibit/poster area.
Scientifi c sessions commence at 8:30AM and run until 5:00PM in the
plenary room each day.
Networking breaks and lunch each day with sponsors in exhibit/poster area.
Tuesday and Wednesday at 5:30PM – cocktail reception with sponsors
in exhibit/poster area.
Wednesday 7:30PM – 10:00PM Gala Dinner sponsored by Inovio and
VGXI, Poster Award Presentation and other presentations.
